Gland Pharma Ltd is a pharmaceutical company based in India with a focus on developing, manufacturing, and marketing complex injectables. The company has a medium risk rating score of 27.2 in terms of ESG (environment, sustainability, and governance). Gland Pharma Ltd offers a wide range of key molecules including Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, and Daptomycin Injection. Additionally, the company is involved in various therapeutic categories such as Anti-Infectives, Anesthetics, Anti-Coagulants, Cardiology, and more. With a majority of revenue coming from the USA, Gland Pharma Ltd. is a prominent player in the pharmaceutical industry.